Lupin Limited has informed the Exchange about press release dated 18-Apr-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Tenofovir Alafenamide Tablets.
Lupin Limited has informed the Exchange about press release dated 18-Apr-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Tenofovir Alafenamide Tablets.